Acute spinal cord injury: contemporary management and novel therapies
Open Access
- 3 April 2026
- journal article
- Published by Asian Spine Journal (ASJ) in Asian Spine Journal
Abstract
Acute spinal cord injury (SCI) remains a life-threatening condition associated with substantial morbidity, mortality, and long-term disability. Despite the advances in trauma systems, surgical techniques, and critical care, the optimal management strategies for acute SCI continue to improve, and clinical practice remains heterogeneous across institutions. The pathophysiology of acute SCI involves an irreversible primary mechanical insult, followed by a dynamic secondary injury cascade characterized by ischemia, inflammation, excitotoxicity, and apoptotic cell death. Early neurological assessments using standardized clinical scales, along with advanced imaging, particularly magnetic resonance imaging, play a crucial role in injury characterization, prognostication, and treatment planning. The contemporary acute management of this condition focuses on the prevention of secondary injury through hemodynamic optimization, early stabilization, and timely surgical decompression. Growing evidence has supported early decompressive surgery, particularly within 24 hours after injury, to improve neurological outcomes. However, the optimal timing, surgical strategy, and patient selection process remain areas of ongoing debate. Pharmacologic neuroprotection, including high-dose methylprednisolone, has become increasingly controversial, while novel agents such as riluzole and minocycline have shown promising but inconclusive results in clinical trials. Beyond conventional management, novel therapeutic approaches-including cell-based therapies, biologics targeting neuroregeneration, neuromodulation, and advanced rehabilitation technologies-have been actively investigated. In parallel, advances in artificial intelligence and predictive modeling are beginning to influence early prognostication and individualized treatment strategies. This review aimed to synthesize current evidence regarding the assessment and management of acute SCI, highlight key controversies, and discuss novel therapies that may shape future clinical practice.Keywords
This publication has 52 references indexed in Scilit:
- Traumatic spinal cord injury: a review of the current state of art and future directions – what do we know and where are we going?North American Spine Society Journal (NASSJ), 2025
- Ultra-early (≤8 hours) surgery for thoracolumbar spinal cord injuries: A systematic review and meta-analysisNorth American Spine Society Journal (NASSJ), 2023
- Intravenous infusion of auto serum-expanded autologous mesenchymal stem cells in spinal cord injury patients: 13 case seriesClinical Neurology and Neurosurgery, 2021
- Indications and interventions of damage control orthopedic surgeries: an expert opinion surveyEuropean Journal of Trauma and Emergency Surgery, 2020
- Development of an unsupervised machine learning algorithm for the prognostication of walking ability in spinal cord injury patientsThe Spine Journal, 2020
- A First-in-Human, Phase I Study of Neural Stem Cell Transplantation for Chronic Spinal Cord InjuryCell Stem Cell, 2018
- Traumatic spinal cord injuryNature Reviews Disease Primers, 2017
- Cell transplantation therapy for spinal cord injuryNature Neuroscience, 2017
- Percutaneous pedicle screw fixation in polytrauma patientsEuropean Spine Journal, 2013
- Administration of Methylprednisolone for 24 or 48 Hours or Tirilazad Mesylate for 48 Hours in the Treatment of Acute Spinal Cord InjuryJAMA, 1997